ArticleScience advances2021

Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancer.

Chunhua Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.